首页> 外文期刊>Science >Akt-Mediated Regulation of Autophagy and Tumorigenesis Through Beclin 1 Phosphorylation
【24h】

Akt-Mediated Regulation of Autophagy and Tumorigenesis Through Beclin 1 Phosphorylation

机译:通过Beclin 1磷酸化的Akt介导的自噬和肿瘤发生的调节。

获取原文
获取原文并翻译 | 示例
       

摘要

Aberrant signaling through the class I phosphatidylinositol 3-kinase (PI3K)-Akt axis is frequent in human cancer. Here, we show that Beclin 1, an essential autophagy and tumor suppressor protein, is a target of the protein kinase Akt. Expression of a Beclin 1 mutant resistant to Akt-mediated phosphorylation increased autophagy, reduced anchorage-independent growth, and inhibited Akt-driven tumorigenesis. Akt-mediated phosphorylation of Beclin 1 enhanced its interactions with 14-3-3 and vimentin intermediate filament proteins, and vimentin depletion increased autophagy and inhibited Akt-driven transformation. Thus, Akt-mediated phosphorylation of Beclin 1 functions in autophagy inhibition, oncogenesis, and the formation of an autophagy-inhibitory Beclin 1/14-3-3/vimentin intermediate filament complex. These findings have broad implications for understanding the role of Akt signaling and intermediate filament proteins in autophagy and cancer.
机译:通过I类磷脂酰肌醇3-激酶(PI3K)-Akt轴的异常信号在人类癌症中很常见。在这里,我们显示Beclin 1,必不可少的自噬和肿瘤抑制蛋白,是蛋白激酶Akt的目标。对Akt介导的磷酸化有抗性的Beclin 1突变体的表达增加自噬,减少锚定非依赖性生长,并抑制Akt驱动的肿瘤发生。 Beklin 1的Akt介导的磷酸化增强了它与14-3-3和波形蛋白中间丝蛋白的相互作用,波形蛋白的耗竭增加了自噬并抑制了Akt驱动的转化。因此,Akt介导的Beclin 1磷酸化在自噬抑制,致癌作用以及自噬抑制性Beclin 1 / 14-3-3 /波形蛋白中间丝复合物的形成中起作用。这些发现对理解Akt信号传导和中间丝蛋白在自噬和癌症中的作用具有广泛的意义。

著录项

  • 来源
    《Science》 |2012年第6109期|956-959|共4页
  • 作者单位

    Department of Dermatology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA. ,Center for Autophagy Research, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.;

    Center for Autophagy Research, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.,Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.,Howard Hughes Medical Institute, University of Texas South-western Medical Center, Dallas, TX 75390, USA.;

    Center for Autophagy Research, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.,Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.;

    Center for Autophagy Research, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.,Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.,Howard Hughes Medical Institute, University of Texas South-western Medical Center, Dallas, TX 75390, USA.;

    Department of Clinical Sciences, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.;

    Department of Pathology and Cell Biology, Columbia University Medical Center and New York Presbyterian Hospital, New York, NY 10032, USA.;

    Department of Cell Biology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.;

    Institute of Cellular Medicine, University of Newcastle, Framlington Place, NE2 4HH Newcastle upon Tyne, UK.;

    Center for Autophagy Research, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.,Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.,Howard Hughes Medical Institute, University of Texas South-western Medical Center, Dallas, TX 75390, USA. ,Department of Microbiology, University of Texas South-western Medical Center, Dallas, TX 75390, USA.;

  • 收录信息 美国《科学引文索引》(SCI);美国《工程索引》(EI);美国《生物学医学文摘》(MEDLINE);美国《化学文摘》(CA);
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

  • 入库时间 2022-08-18 02:53:38

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号